ESC Professional Premium Access

Performance assessment of unfractionated heparin protocol in pediatric patients supported on extracorporeal membrane oxygenation

Congress Presentation

About the speaker

Ms Eman Shorog

king khalid university, Abha (Saudi Arabia)
0 follower

7 more presentations in this session

Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence

Speaker: Doctor J. Harrington (Durham, US)

Thumbnail

Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme

Speaker: Professor R. De Caterina (Pisa, IT)

Thumbnail

D-dimer-driven versus standard prophylactic anticoagulation with fondaparinux in critically ill patients with COVID-19 and coagulopathy: an open-label, randomized controlled trial

Speaker: Doctor L. Adrian (Malang, ID)

Thumbnail

Real-world effectiveness and safety of edoxaban in patients with and without a history of ischaemic stroke: results from the ETNA-AF programme

Speaker: Professor R. De Caterina (Pisa, IT)

Thumbnail

Protective effect of proton pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta-analysis

Speaker: Doctor H. Ahn (Seoul, KR)

Thumbnail

Access the full session

How to balance efficacy and safety of anticoagulant therapy in clinical practice

Speakers: Ms E. Shorog, Doctor J. Harrington, Professor R. De Caterina, Doctor L. Adrian, Professor R. De Caterina...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk